Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
24 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-announces-launch-of-authorized-generic-of-maxitrol-neomycin-and-polymyxin-b-sulfates-and-dexamethasone-ophthalmic-suspension-302436485.html
23 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-presenting-patient-data-and-patient-experience-study-for-lacrifill-canalicular-gel-a-novel-therapy-for-dry-eye-at-the-american-society-of-cataract-and-refract-302435031.html
28 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nordic-group-bv-through-its-subsidiary-nordic-pharma-inc-us-announces-details-of-lacrifill-canalicular-gel-poster-presentation-at-seco-2025-302388666.html
17 Oct 2024
// BUSINESSWIRE
12 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alex-therapeutics-has-signed-an-exclusive-agreement-with-navamedic-for-the-development-of-a-companion-app-to-aid-in-the-treatment-of-parkinsons-disease-302246418.html
27 Jun 2024
// PHARMABIZ
ABOUT THIS PAGE